New award for tamsulosin HCL 0.4MG capsules with exelan pharmaceuticals INC. Ordering period is sept. 7, 2025 to sept. 6, 2026 with four one-year options
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0036
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Tamsulosin Capsules Pre-Solicitation · 36E79725R0011 · Posted Dec 16, 2024
- Last date to order 59% complete
- IDV ceiling
- $88,222,846.59
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for Tamsulosin Hydrochloride 0.4 mg capsules on September 7, 2025, with a ceiling of $88,222,846.59. No set-aside was used.
Work is performed at Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary performance locations in Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and designated federal delivery locations as specified by contracting agencies. The contract supports multiple federal agencies including the Veterans Affairs National Acquisition Center, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through VA and DoD Pharmaceutical Prime Vendor Programs.
The originating solicitation, posted December 16, 2024 with responses due January 21, 2025, sought supply of capsules in specific packaging configurations—safety caps convertible to non-safety caps, 120 cc minimum bottle volume, 5.75 inches minimum circumference—with annual estimated requirements of 1,405,849 bottles of 90-count capsules, and optional volumes of 368,454 bottles of 500-count or 184,227 bottles of 1,000-count capsules. The procurement used NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals).
The ordering period runs from September 7, 2025 through September 6, 2026, with four one-year options exercisable through ultimate completion on September 6, 2027.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0036?
36E79725D0036 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on September 7, 2025.
How much is contract 36E79725D0036 worth?
36E79725D0036's own ceiling is $88,222,847.
Who can order from contract 36E79725D0036?
36E79725D0036 is a single award indefinite delivery contract.
Was contract 36E79725D0036 competed?
The extent of competition for 36E79725D0036 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV